Citation Impact
Citing Papers
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
2014 Standout
Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation
2009 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
MiRP1 Forms IKr Potassium Channels with HERG and Is Associated with Cardiac Arrhythmia
1999 Standout
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes
2007
Activity of daptomycin against susceptible and multidrug-resistant Gram-positive pathogens collected in the SECURE study (Europe) during 2000-2001
2003
Guidelines for clinical intracardiac electrophysiological and catheter ablation procedures
1995
Impaired Fasting Glucose, Diabetes Mellitus, and Cardiovascular Disease Risk Factors are Associated with Prolonged QTc Duration. Results from the Third National Health and Nutrition Examination Survey
2001
5-HT2 receptors modulate excitatory neurotransmission to cardiac vagal neurons within the nucleus ambiguus evoked during and after hypoxia
2009 StandoutNobel
A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
2010 Standout
Minimally Invasive Left Ventricular Epicardial Lead Placement: Surgical Techniques for Heart Failure Resynchronization Therapy
2005
Implantable Defibrillators for the Prevention of Mortality in Patients With Nonischemic Cardiomyopathy
2004
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Epicardial Left Ventricular Lead Placement for Cardiac Resynchronization Therapy Following Failed Coronary Sinus Approach
2006
Short-term and medium-term health effects of 9/11
2011
Reducing Unnecessary Right Ventricular Pacing with the Managed Ventricular Pacing Mode in Patients with Sinus Node Disease and AV Block
2006
A New Paradigm for Physiologic Ventricular Pacing
2006
Exercise Standards for Testing and Training
2013 Standout
Cardiac Actions of Erythromycin
1998
Recommendations from the Heart Rhythm Society Task Force on Device Performance Policies and Guidelines
2006
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
2011 Standout
Sex Differences in Guanfacine Effects on Drug Craving and Stress Arousal in Cocaine-Dependent Individuals
2014
Assessment of Left Atrial Appendage Structure and Function by Transesophageal Echocardiography
1998
Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events
2009 Standout
The REDCap consortium: Building an international community of software platform partners
2019 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Exposure to Traffic and the Onset of Myocardial Infarction
2004
Syncope in the Patient with Nonischemic Dilated Cardiomyopathy
2004
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Sarcoidosis
2013 Standout
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Effects of stress on the development and progression of cardiovascular disease
2017
A randomized comparison ofatrial and dual-chamber pacing in177 consecutive patients with sick sinus syndrome
2003
ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices—Summary Article
2002
Myocarditis
2011 Standout
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
2009 Standout
Pacemaker implantation and quality of life in the Mode Selection Trial (MOST)
2006
Psychological Stress and Cardiovascular Disease
2008 Standout
Stress and cardiovascular disease
2012
ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Summary Article
2002
Prospective Randomized Study of Mode Switching in a Clinical Trial of Pacemaker Therapy for Sinus Node Dysfunction
2004
Relating protein pharmacology by ligand chemistry
2007 Standout
Glocal Clinical Registries: Pacemaker Registry Design and Implementation for Global and Local Integration – Methodology and Case Study
2013
Percent right ventricular pacing predicts outcomes in the DAVID trial
2005
Addendum to “Personal and Public Safety Issues Related to Arrhythmias that May Affect Consciousness: Implications for Regulation and Physician Recommendations: A Medical/Scientific Statement from the American Heart Association and the North American Society of Pacing and Electrophysiology”
2007
Obstructive sleep apnoea and its cardiovascular consequences
2008 Standout
The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency
2003
QT Interval Prolongation in Future SIDS Victims: A Polysomnographic Study
2008
Acquired QT interval prolongation and HERG: implications for drug discovery and development
2004
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
2009 Standout
Minimizing Ventricular Pacing to Reduce Atrial Fibrillation in Sinus-Node Disease
2007
Biventricular Pacing for Atrioventricular Block and Systolic Dysfunction
2013
Myocarditis
2009 Standout
Atrial Overdrive Pacing in Patients with Sleep Apnea with Implanted Pacemaker
2005
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
Fluorine in medicinal chemistry
2007 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Canadian Trial of Physiological Pacing
2004
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
Magnesium in Man: Implications for Health and Disease
2014 Standout
Adverse Effect of Ventricular Pacing on Heart Failure and Atrial Fibrillation Among Patients With Normal Baseline QRS Duration in a Clinical Trial of Pacemaker Therapy for Sinus Node Dysfunction
2003
Policy: NIH to balance sex in cell and animal studies
2014 StandoutNature
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2019 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease
2008 Standout
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Long-Term Outcomes After Catheter Ablation of Cavo-Tricuspid Isthmus Dependent Atrial Flutter
2009
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
2006
The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes
2006
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
Sampling the Antibiotic Resistome
2006 StandoutScience
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Mechanisms of Plaque Formation and Rupture
2014 Standout
Alterations of heart rate and of heart rate variability after radiofrequency catheter ablation of supraventricular tachycardia. Delineation of parasympathetic pathways in the human heart.
1993
Management of listeriosis
1997
Correction: Glocal Clinical Registries: Pacemaker Registry Design and Implementation for Global and Local Integration – Methodology and Case Study
2013
2001
Contemporary Definitions and Classification of the Cardiomyopathies
2006 Standout
Physical, Psychological and Chemical Triggers of Acute Cardiovascular Events
2011
Contemporary Pacemaker and Defibrillator Device Therapy
2007
Outcome and Complications After Implantable Cardioverter Defibrillator Therapy in Hypertrophic Cardiomyopathy
2012
Heart Failure During Cardiac Pacing
2006
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Atrial High Rate Episodes Detected by Pacemaker Diagnostics Predict Death and Stroke
2003
Particulate Matter Air Pollution and Cardiovascular Disease
2010 Standout
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive Summary
2006
Antibiotic Resistance in Listeria spp
1999 StandoutNobel
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2006
Pacing for drug-refractory or drug-intolerant hypertrophic cardiomyopathy
2012
Heart Rate Variability
1996 Standout
Recent advances in pacemaker and implantable defibrillator therapy for young patients
2004
Cost-Effectiveness of Dual-Chamber Pacing Compared With Ventricular Pacing for Sinus Node Dysfunction
2005
Baseline Study To Determine In Vitro Activities of Daptomycin against Gram-Positive Pathogens Isolated in the United States in 2000-2001
2003
Consensus Statement: Consensus Statement of the European Heart Rhythm Association: Updated Recommendations for Driving by Patients with Implantable Cardioverter Defibrillators
2010
Left ventricular function during and after right ventricular pacing
2004
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram
2009 Standout
Prevention of Ventricular Desynchronization by Permanent Para-Hisian Pacing After Atrioventricular Node Ablation in Chronic Atrial Fibrillation
2006
2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2012
Cardiovascular Outcomes With Atrial-Based Pacing Compared With Ventricular Pacing
2006
Works of Frederick Ehlert being referenced
Resumption of Driving after Life-Threatening Ventricular Tachyarrhythmia
2001
Persistent inappropriate sinus tachycardia after radiofrequency current catheter modification of the atrioventricular node
1992
Gender differences in heart rate before and after autonomic blockade: Evidence against an intrinsic gender effect
1996
Robotically assisted left ventricular epicardial lead implantation for biventricular pacing
2003
Follow‐Up of Patients with Unexplained Syncope and Inducible Ventricular Tachyarrhythmias: Analysis of the AVID Registry and an AVID Substudy
2001
Effectiveness of radiofrequency catheter ablation for treatment of atrial tachycardia
1993
Diurnal pattern of QTc interval: How long is prolonged?
1996
Gender-Specific Differences in the QT Interval and the Effect of Autonomic Tone and Menstrual Cycle in Healthy Adults
1997
Relation of 12-Lead Electrocardiogram Patterns to Implanted Defibrillator-Terminated Ventricular Tachyarrhythmias in Hypertrophic Cardiomyopathy
2009
Increased incidence of life-threatening ventricular arrhythmias in implantable defibrillator patients after the World Trade Center attack
2004
Ventricular Pacing or Dual-Chamber Pacing for Sinus-Node Dysfunction
2002
Radiofrequency catheter ablation of atrial flutter: Procedural success and long-term outcome
1995
In vitro activity of LY146032 (Daptomycin), a new peptolide
1987
980-89 Lack of Evidence for Atrial Stunning After DC Shock in Patients in Normal Sinus Rhythm Undergoing ICD Insertion: A Study Using TEE
1995
Pacing in obstructive hypertrophic cardiomyopathy: a therapeutic option?
2006